| Eli Lilly (Suisse) SA - Zyprexa, poudre pour solution injectable 5 mg/ml |
| 55692 | | 01 | | Zyprexa, poudre pour solution injectable 5 mg/ml | | | | N05AH03 | | Olanzapine | | 20.12.2001 | | |
|
| Composition |
| Praeparatio cryodesiccata: olanzapinum 10 mg, lactosum monohydricum, acidum hydrochloridum dilutum, natrii hydroxidum, acidum tartaricum pro vitro corresp. natrium 100 µg. |
| Packungsbestandteile |
| Praeparatio cryodesiccata: | | | | | | | | Active Agent | Dose |
|---|
| Olanzapine | 10 mg |
| | BAG: Active Agent | Dose |
|---|
| Olanzapine | 10 mg |
| | | | Inactive agents |
|---|
| Acidum Hydrochloridum Dilutum | | Tartaric Acid | | Lactose Monohydrate | | Sodium Hydroxide |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | Flasche(n) | 6.33 | 15.50 | B | SL | Yes |
|
